Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (56)

2024

  1. Cognitive Reserve in Parkinson's Disease without Dementia: β-Amyloid and Metabolic Assessment

    Movement Disorders Clinical Practice, Vol. 11, Núm. 3, pp. 282-288

2023

  1. A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  2. A circuit-based approach to modulate hypersexuality in Parkinson's disease

    Psychiatry and Clinical Neurosciences, Vol. 77, Núm. 4, pp. 223-232

  3. Abnormal functional connectivity in radiologically isolated syndrome: A resting-state fMRI study

    Multiple Sclerosis Journal, Vol. 29, Núm. 11-12, pp. 1393-1405

  4. Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease

    Journal of Neuroimaging, Vol. 33, Núm. 6, pp. 953-959

  5. Longitudinal assessment of social cognition in de novo Parkinson's disease patients and its relationship with dopaminergic innervation

    Behavioural Brain Research, Vol. 454

  6. Noninvasive modulation of human corticostriatal activity

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 15

  7. Unilateral focused ultrasound subthalamotomy in early Parkinson's disease: A pilot study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 95, Núm. 3, pp. 206-213

2022

  1. An fMRI meta-analysis of the role of the striatum in everyday-life vs laboratory-developed habits

    Neuroscience and Biobehavioral Reviews, Vol. 141

  2. Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer’s Disease: A Double-Blind Masked Clinical Trial for Dose Finding

    Journal of Prevention of Alzheimer's Disease, Vol. 9, Núm. 3, pp. 425-434

  3. Loneliness as Risk Factor for Alzheimer´s disease

    Current Aging Science

  4. Neuroanatomical and psychological considerations in temporal lobe epilepsy

    Frontiers in Neuroanatomy, Vol. 16

  5. Neuropsychological, Neuropsychiatric, and Clinical Correlates of Affective and Cognitive Theory of Mind in Parkinson’s Disease: A Meta-Analysis

    Neuropsychology, Vol. 36, Núm. 6, pp. 483-504

  6. Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ́s disease

    Clinical Parkinsonism and Related Disorders, Vol. 7

  7. Seroprevalence of anti-SARS-CoV-2 IgG antibodies: relationship with COVID-19 diagnosis, symptoms, smoking, and method of transmission

    IJID Regions, Vol. 4, pp. 10-16

  8. Striatal Blood–Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study

    Movement Disorders, Vol. 37, Núm. 10, pp. 2057-2065

  9. The motor inhibitory network in patients with asymmetrical Parkinson’s disease: An fMRI study

    Brain Imaging and Behavior, Vol. 16, Núm. 3, pp. 1349-1361

2021

  1. Aberrant Salient and Corticolimbic Connectivity in Hypersexual Parkinson's Disease

    Brain Connectivity, Vol. 11, Núm. 8, pp. 639-650

  2. Alzheimer's Disease and Empathic Abilities: The Proposed Role of the Cingulate Cortex

    Journal of Alzheimer's Disease Reports, Vol. 5, Núm. 1, pp. 345-352

  3. Bilateral staged magnetic resonance-guided focused ultrasound thalamotomy for the treatment of essential tremor: A case series study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 92, Núm. 9, pp. 927-931